eSign.AI Named Sole Electronic Signature Technology Provider for Hong Kong Government's CorpID Project, Building the Foundation for Digital Signing Infrastructure in Hong Kong
HONG KONG, May 8, 2026 /PRNewswire/ — As Hong Kong’s Digital Corporate…
Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to 'RZ-001' for Hepatocellular Carcinoma
RMAT designation based on promising Phase 1b/2a clinical data, including safety profile and preliminary response rates, with trans-splicing ribozyme-based…